References
- Vane, J. R. : Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Boil) 231, 232 (1971) https://doi.org/10.1038/newbio231232a0
- Chang, H. W. and Jahang, Y. : Selective cyclooxygenase-2 inhibitors as anti-inflammatory Agents. Korean J. of Med. Chem. 8, 48 (1998)
- Kwon, S. K. : SAR of COX-2 inhibitors. J. Appl. Pharmacol. 9, 69 (2001).
- Fletcher, B. S., Smith, W. L. and DeWittt, D. L. : J. Biol. Chem. 268, 6610 (1992)
- Gans, K. R., Galgraith, W., Roman, R. J., Haber, S. B., Kerr, J. S., Schmidt, W. K., Smith, C., Hewes, W. E. and Ackerman, N. R. : Antiinflammatory and safety profile of DuP-697, a novel orally effective prostaglandin synthesis inhibitor. J. Pharmacol. Exp. T her. 254, 180 (1990)
- Wilkerson, W. W. : Antiinflammatory 2-halo-4,5-diarylpyrrols, U.S. Pat. 4652582 (1987)
- Wilkerson, W. W., Galbraith, W., Gans-Brangs, K., Grubb, M., Hewes, W. E., Jaffee, B., Kenney, J. P., Kerr, J. and Wong, N : Antinflammatory 4,5-diarylpyrroles: synthesis and QSAR. J. Med. Chem. 37, 988 (1994)
- Graham Solomons, T. W. and Fryhle, C. B. : Organic chemistry, Wiley, pp. 366-402, 723 (2000)
- Wilkerson, W. W., Copeland, R. A. Covinton, M. and Trazaskos ,J. M. : Antiinflammatory 4,5-diarylpyrroles 2. Activity as a function of cyclooxygenase-2 inhibition. J. Med. Chem. 38, 3895 (1995)
- Janusz, J. M., Young, P. A., Ridgeway, J. M. and Scherz, M. W. : New cycloxygenase-2/5-lipoxygenase inhibitors. 1., J Med. Cham. 41, 1112 (1998)
- Acheson, R. M. : An introduction to the chemistry of heterocyclic compounds, Wiely International Edition, pp. 300-327 (1967)
- Janusz , J. M., Young, P. A., Scherz , M. W. and Enzweiler, K. : New cyclooxygenase-2/5-lipoxygenase inhibitors. 2, J. Med. Chem. 41, 1124 (1998) https://doi.org/10.1021/jm970680p
- Talley, J. J., Brown, D. L., Carter, J. S., Graneto, M. J., Koboldt, C. M., Masferrer, J. L., Perkins, W. E., Rogers, R. S., Shaffer, A. F., Zhang, Y. Y., Zweifel, B. S. and Seibert, K. : 4-[5-Methyl-3-phenylisoxazol-4-yl]-benzenesulfo- namide, Valdecoxib: A potent and selective inhibitor of COX-2. J. Med. Chem. 43, 775 (2000).
- Kwon. S. K. and Park, M. S.: Synthesis of methoxybenzoylbenzisothiazine derivatives by Gabriel-Colman rearrangement. J. Kor. Chem. Soc. 40, 678 (1996)
- Penning, T. D., Talley, J. J., Bertenshaw, S. R., Carter,J. S., Collins, P. W., Docter, S., Graneto, M. J., Lee, L. F., Malecha, J. W., Niyashiro, J. M., Roger, R. S., Rogier, D. J. and Yu, S. S. : Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 Inhibitors: Identification of 4-[5-(4-methylphenyl)-3-(trifluoro-methyl)-1H-pyrazol-1-yl)]benzenesulfonamide (SC-58635, Celecoxib). J. Med. Chem. 40, 1347 (1997).
- Li, J. P. : Synthesis of 1-substituted and 1,3-disubstituted 5hydantoin carboxylates. J. Org. Chem. 40, 3414 (1975) https://doi.org/10.1021/jo00911a024
- Park, M. S. and Park, H. S. : Synthesis of N-aryl pbromophenylglycine O-alkyl ester and its substitution of ester moiety. Yakhak Hoeji 47, 276 (2003)
- Smith, J. B. and Willis, A. L. : Aspirin selectivity inhibits prostaglandin production in human platelets. Nature (New BioI) 231, 235 (1971) https://doi.org/10.1038/newbio231235a0
- Copeland, R. A., Williams, J. N., Giannaras, J., Nurnberg, S., Covington, M., Pinto, D. and Pick, S. : Proc. Natl. Acad. Sci. USA 91, 11203 (1994)